Search

everythinglearnresearchcommunity

for

Search:↓

Human dermal fibroblasts are the main cells targeted by a virus that can cause a deadly skin cancer, and a certain inhibitor can effectively block this infection.

Some new isatin compounds could be strong cancer-fighting drugs because they fit well in cancer-related proteins and have good drug-like properties.

Tyrosine kinase inhibitors show promise in treating some skin diseases but their definitive role in dermatology is still unclear.

PRIDE syndrome helps identify skin side effects from EGFR inhibitors like erlotinib.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

TNFα and interleukin-1 blockers reduce skin inflammation from EGFR antibody therapy.

Topical aprepitant reduces skin rash and hair loss caused by cancer treatment.

Certain derivatives are more effective 5α-reductase type 2 inhibitors than finasteride.

Skin side effects from EGFR inhibitor cancer treatment can be managed effectively, often without stopping the medication.

New research is needed to create better drugs that block the enzyme responsible for conditions like male baldness and prostate enlargement.

The MAPK/ERK pathway is crucial in controlling cell growth and death in finasteride-induced hypospadias.

Blocking EGFR in skin cells doesn't majorly increase inflammation markers.

Janus Kinase Inhibitors are promising new treatments for various skin conditions due to their effectiveness and safety.

Some curcumin-like compounds can effectively and safely block the enzyme linked to hair loss and other conditions related to male hormones.

Danoprevir, remdesivir, and saridegib may effectively inhibit SARS-CoV-2.

EGFR inhibitors cause skin issues and hair loss by weakening skin defenses, suggesting antibiotics and targeted treatments can help.

Two new compounds can block androgen receptor activity in different ways and may lead to new treatments for androgen-related diseases.

New hybrid compound found to effectively prevent hair loss.

Blocking casein kinase 1 in skin cells can help melanocyte precursors move better, potentially helping with conditions like vitiligo or gray hair.

Certain drugs that block specific enzymes can help treat prostate diseases.

MOTILIPERM may help treat male infertility by reducing stress in cells.

New indole-based compounds, particularly cemtirestat, show promise as dual-function drugs for diabetic complications.

Skin side effects from cancer drugs targeting EGFR can affect treatment adherence but can be managed with antibiotics like tetracycline.

Certain inhibitors slow down plant growth by causing early cell specialization without changing the cell development pattern.

ZD1839, a cancer drug, can cause mild skin rashes that are treatable without stopping the medication.

ISCK03 stops melanin production in human melanoma cells and lightens skin color in mice and guinea pigs.

GI198745 is more potent and longer-lasting than finasteride, potentially better for treating hair loss.

Ivarmacitinib significantly improved hair regrowth in severe alopecia areata after tofacitinib was less effective.

JAK inhibitors help hair growth by boosting beta-catenin activity in hair root cells.